Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Characterizing the Neuropharmacology of Dexmedetomidine Through Trimodal Imaging

NCT05435560 is registered in ClinicalTrials.gov with Massachusetts General Hospital as lead sponsor.

NCT NCT05435560
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05435560 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Characterizing the Neuropharmacology of Dexmedetomidine Through Trimodal Imaging
Lead sponsor
Massachusetts General Hospital
Phase
Phase 1
Overall status
Unknown status
Start date
April 12, 2022
Completion date
April 30, 2023
Enrollment
30 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

anesthesia, healthy